For some freak reason, Israel, which produces so much good for the world, is the most hated nation. Go figure.
Vaxil BioTherapeutics’s ImMucin trains immune system to fight cancer cells and prevent the disease’s return for early stages and remission.
An Israeli biotech company is developing a vaccine for cancer that it says can help prevent the return of the lethal disease for 90% of the differenttypes of cancer.
Vaxil BioTherapeutics based in Nes Ziona has been developing ImMucin for more than five years, and already has seen strong success in testing indicating it can be a vital tool in combating cancer. The disease kills eight million people worldwide per year, and sees 14 million new cases diagnosed annually according to the World Health Organization.
Their approach sounds quite similar to one developed in the US that was recently featured on “60 Minutes.”